home All News open_in_new Full Article

Thousands of NHS patients denied breakthrough Alzheimer’s drugs

Drugs that slow progression of Alzheimer’s don’t provide enough benefit to justify substantial cost for NHS, regulator has said


today 14 h. ago attach_file Events

attach_file Events
attach_file Events
attach_file Politics
attach_file Events
attach_file Events
attach_file Events
attach_file Politics
attach_file Society
attach_file Science
attach_file Science
attach_file Events
attach_file Society
attach_file Society
attach_file Events


ID: 2760567583
Add Watch Country

arrow_drop_down